Role of 5-HT2C receptors in dyskinesia; International Journal of Pharmacy and Pharmaceutical Sciences; Vol. 8, iss. 1
| Parent link: | International Journal of Pharmacy and Pharmaceutical Sciences Vol. 8, iss. 1.— 2016.— [P. 5-10] |
|---|---|
| Autor principal: | Loonen A. J. M. Anton |
| Autor corporatiu: | Национальный исследовательский Томский политехнический университет Институт неразрушающего контроля Кафедра экологии и безопасности жизнедеятельности |
| Altres autors: | Ivanova S. A. Svetlana Aleksandrovna |
| Sumari: | Title screen By integrating knowledge gained by pharmacogenetic, neuroanatomical and pharmacological studies, a model can be constructed how serotonin (5-HT) affects the vulnerability to induce tardive dyskinesia. From neuroanatomical studies, it can be concluded that 5-HT inhibits the release ofdopamine (DA) within the dorsal striatum by affecting 5-HT2C receptors and also within the ventral striatum and prefrontal cortex by affecting 5-HT2A receptors. However, considering the low affinity of DA for its receptors, it is unlikely that the so released DA is able to displace atypicalantipsychotics from DA D2 and D3 receptors. 5-HT2C receptors and, to a lesser extent, 5-HT2A receptors, have constitutive activity and therefore,atypical antipsychotics can have inverse agonistic effects. It is hypothesized that decreasing the activity of 5-HT2 receptor carrying medium spinyneurons (MSNs) within the dorsal striatum represents the mechanism showing how atypical antipsychotics have limited ability to cause tardivedyskinesia. |
| Idioma: | anglès |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | http://innovareacademics.in/journals/index.php/ijpps/article/view/8736 |
| Format: | Electrònic Capítol de llibre |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=649685 |
Ítems similars
Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia; Pharmacogenomics; Vol. 20, iss. 17
per: Loonen A. J. M. Anton
Publicat: (2019)
per: Loonen A. J. M. Anton
Publicat: (2019)
Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia; Journal of Pharmacy and Pharmaceutical Sciences (JPPS); Vol. 21
Publicat: (2018)
Publicat: (2018)
Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors; The World Journal of Biological Psychiatry; Latest Articles
Publicat: (2018)
Publicat: (2018)
Pharmacokinetic studies of new silver-based complex; International Journal of Pharmacy and Pharmaceutical Sciences; Vol. 7, iss. 6
per: Silnikov V. A. Vladimir
Publicat: (2015)
per: Silnikov V. A. Vladimir
Publicat: (2015)
5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia; Frontiers in Molecular Neuroscience; Vol. 13
Publicat: (2020)
Publicat: (2020)
Association of Polymorphisms of Serotonin Transporter (5HTTLPR) and 5-HT2C Receptor Genes with Criminal Behavior in Russian Criminal Offenders; Neuropsychobiology; Vol. 75, iss. 4
Publicat: (2017)
Publicat: (2017)
Investigation genotoxicity of new silver-based complexwith antimicrobial activity; International Journal of Pharmacy and Pharmaceutical Sciences; Vol. 7, iss. 7
per: Plotnikov E. V. Evgeny Vladimirovich
Publicat: (2015)
per: Plotnikov E. V. Evgeny Vladimirovich
Publicat: (2015)
Consider Role of Glutamatergic Habenula-projecting Globus Pallidus in OCD; Pharmacopsychiatry; Vol. 52, iss. 14
per: Loonen A. J. M. Anton
Publicat: (2019)
per: Loonen A. J. M. Anton
Publicat: (2019)
Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations; SAGE Open Medicine; Vol. 4
Publicat: (2016)
Publicat: (2016)
Circuits regulating pleasure and happiness: evolution and role in mental disorders; Acta Neuropsychiatrica; Vol. 30, iss. 1
per: Loonen A. J. M. Anton
Publicat: (2018)
per: Loonen A. J. M. Anton
Publicat: (2018)
Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression; Frontiers in Pharmacology; Vol. 10
Publicat: (2019)
Publicat: (2019)
Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy
Publicat: (2022)
Publicat: (2022)
Association Study Indicates a Protective Role of Phosphatidylinositol-4-Phosphate-5-Kinase against Tardive Dyskinesia; International Journal of Neuropsychopharmacology (IJNP); Vol. 18, iss. 6
Publicat: (2015)
Publicat: (2015)
Receptor-Receptor Interactions in the Central Nervous System
Publicat: (2018)
Publicat: (2018)
No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic‐induced tardive dyskinesia; Human Psychopharmacology: Clinical and Experimental; Vol. 34, iss. 1
Publicat: (2019)
Publicat: (2019)
The Role of Cardiac Opioid Receptors in the Cardioprotective Effect of Continuous Normobaric Hypoxia; Bulletin of Experimental Biology and Medicine; Vol. 168, iss. 6
Publicat: (2020)
Publicat: (2020)
Receptor Binding
Publicat: (1986)
Publicat: (1986)
Neurobiological mechanisms associated with antipsychotic drug-induced dystonia; Journal of Psychopharmacology; Vol. 35, iss. 1
per: Loonen A. J. M. Anton
Publicat: (2021)
per: Loonen A. J. M. Anton
Publicat: (2021)
Evolution of circuits regulating pleasure and happiness with the habenula in control; CNS Spectrums; Vol. 24, iss. 2
per: Loonen A. J. M. Anton
Publicat: (2019)
per: Loonen A. J. M. Anton
Publicat: (2019)
The evolutionary old forebrain as site of action to develop new psychotropic drugs; Journal of Psychopharmacology; Vol. 32, iss. 12
per: Loonen A. J. M. Anton
Publicat: (2018)
per: Loonen A. J. M. Anton
Publicat: (2018)
Circuits Regulating Pleasure and Happiness: The Evolution of the Amygdalar-Hippocampal-Habenular Connectivity in Vertebrates; Frontiers in Neuroscience; Vol. 10, iss. 539
per: Loonen A. J. M. Anton
Publicat: (2016)
per: Loonen A. J. M. Anton
Publicat: (2016)
Colloid and Interface Science in Pharmaceutical Research and Development
per: Hiroyuki Ohshima
Publicat: (Amsterdam, Elsevier, 2014)
per: Hiroyuki Ohshima
Publicat: (Amsterdam, Elsevier, 2014)
Circuits regulating pleasure and happiness - focus on potential biomarkers for circuitry including the habenuloid complex; Acta Neuropsychiatrica; Vol. 34, iss. 5
per: Loonen A. J. M. Anton
Publicat: (2022)
per: Loonen A. J. M. Anton
Publicat: (2022)
Deliquescence: Hygroscopicity of Water-Soluble Crystalline Solids; Journal of Pharmaceutical Sciences; Vol. 104, iss. 11
per: Tereshchenko A. G. Anatoly Georgievich
Publicat: (2015)
per: Tereshchenko A. G. Anatoly Georgievich
Publicat: (2015)
Glutamate Receptors Methods and Protocols /
Publicat: (2019)
Publicat: (2019)
Immune Receptors Methods and Protocols /
Publicat: (2022)
Publicat: (2022)
Olfactory Receptors Methods and Protocols /
Publicat: (2018)
Publicat: (2018)
Steroid Receptors Methods and Protocols /
Publicat: (2014)
Publicat: (2014)
Olfactory Receptors Methods and Protocols /
Publicat: (2013)
Publicat: (2013)
Immune Receptors Methods and Protocols /
Publicat: (2011)
Publicat: (2011)
Opioid Receptors Methods and Protocols /
Publicat: (2015)
Publicat: (2015)
NMDA Receptors Methods and Protocols /
Publicat: (2024)
Publicat: (2024)
Ítems similars
-
Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia; Pharmacogenomics; Vol. 20, iss. 17
per: Loonen A. J. M. Anton
Publicat: (2019) -
Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia; Journal of Pharmacy and Pharmaceutical Sciences (JPPS); Vol. 21
Publicat: (2018) -
Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors; The World Journal of Biological Psychiatry; Latest Articles
Publicat: (2018) -
Pharmacokinetic studies of new silver-based complex; International Journal of Pharmacy and Pharmaceutical Sciences; Vol. 7, iss. 6
per: Silnikov V. A. Vladimir
Publicat: (2015) -
5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia; Frontiers in Molecular Neuroscience; Vol. 13
Publicat: (2020)